Frederick F. Krass

Array ( [id] => 4380117 [patent_doc_number] => 06303604 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase' [patent_app_type] => 1 [patent_app_number] => 9/590187 [patent_app_country] => US [patent_app_date] => 2000-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16282 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303604.pdf [firstpage_image] =>[orig_patent_app_number] => 590187 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658505 [patent_doc_number] => 07105560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Use of etodolac in the treatment of multiple myeloma' [patent_app_type] => utility [patent_app_number] => 09/589476 [patent_app_country] => US [patent_app_date] => 2000-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 5481 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105560.pdf [firstpage_image] =>[orig_patent_app_number] => 09589476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1166784 [patent_doc_number] => 06756396 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-06-29 [patent_title] => 'Ethylene glycol esters as photoactive agents' [patent_app_type] => B1 [patent_app_number] => 09/588206 [patent_app_country] => US [patent_app_date] => 2000-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 23 [patent_no_of_words] => 5654 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756396.pdf [firstpage_image] =>[orig_patent_app_number] => 09588206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1528338 [patent_doc_number] => 06479481 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)' [patent_app_type] => B1 [patent_app_number] => 09/583902 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4431 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479481.pdf [firstpage_image] =>[orig_patent_app_number] => 09583902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453803 [patent_doc_number] => 06462018 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Fibrin polymer structure' [patent_app_type] => B1 [patent_app_number] => 09/585500 [patent_app_country] => US [patent_app_date] => 2000-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 10839 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462018.pdf [firstpage_image] =>[orig_patent_app_number] => 09585500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1496255 [patent_doc_number] => 06403812 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => '4, 7-Dichlorofluorescein dyes as molecular probes' [patent_app_type] => B1 [patent_app_number] => 09/580754 [patent_app_country] => US [patent_app_date] => 2000-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6942 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403812.pdf [firstpage_image] =>[orig_patent_app_number] => 09580754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595293 [patent_doc_number] => 06384049 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Cancer treatment' [patent_app_type] => B1 [patent_app_number] => 09/578281 [patent_app_country] => US [patent_app_date] => 2000-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6669 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384049.pdf [firstpage_image] =>[orig_patent_app_number] => 09578281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384085 [patent_doc_number] => 06262092 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Mutual salt of amlodipine and atorvastatin' [patent_app_type] => 1 [patent_app_number] => 9/578204 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7138 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262092.pdf [firstpage_image] =>[orig_patent_app_number] => 578204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4312229 [patent_doc_number] => 06316453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Aqueous pharmaceutical composition' [patent_app_type] => 1 [patent_app_number] => 9/573504 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2012 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316453.pdf [firstpage_image] =>[orig_patent_app_number] => 573504 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383711 [patent_doc_number] => 06294582 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Methods for treatment of asthma using S-oxybutynin' [patent_app_type] => 1 [patent_app_number] => 9/574106 [patent_app_country] => US [patent_app_date] => 2000-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2613 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294582.pdf [firstpage_image] =>[orig_patent_app_number] => 574106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4343089 [patent_doc_number] => 06284542 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Oxidative metabolism in smooth muscle cells: Methods and materials relating thereto' [patent_app_type] => 1 [patent_app_number] => 9/571932 [patent_app_country] => US [patent_app_date] => 2000-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11062 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284542.pdf [firstpage_image] =>[orig_patent_app_number] => 571932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580108 [patent_doc_number] => 06423339 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'Liquisolid systems and methods of preparing same' [patent_app_type] => B1 [patent_app_number] => 09/568475 [patent_app_country] => US [patent_app_date] => 2000-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13527 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423339.pdf [firstpage_image] =>[orig_patent_app_number] => 09568475 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5889307 [patent_doc_number] => 20020013342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-31 [patent_title] => 'Treatment of central nervous system disorders with selective estrogen receptor modulators' [patent_app_type] => new [patent_app_number] => 09/564966 [patent_app_country] => US [patent_app_date] => 2000-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14670 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20020013342.pdf [firstpage_image] =>[orig_patent_app_number] => 09564966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1517608 [patent_doc_number] => 06500834 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-31 [patent_title] => 'Composition and method for treatment of cerebral ischemia' [patent_app_type] => B1 [patent_app_number] => 09/552924 [patent_app_country] => US [patent_app_date] => 2000-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2000 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/500/06500834.pdf [firstpage_image] =>[orig_patent_app_number] => 09552924 [rel_patent_id] =>[rel_patent_doc_number] =>)